HHLR ADVISORS, LTD. - Q4 2019 holdings

$8.03 Billion is the total value of HHLR ADVISORS, LTD.'s 54 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 34.4% .

 Value Shares↓ Weighting
IQ SellIQIYI INCsponsored ads$985,724,000
+21.0%
46,694,629
-7.6%
12.28%
+9.6%
BGNE  BEIGENE LTDsponsored adr$907,082,000
+35.4%
5,472,2590.0%11.30%
+22.7%
ALGN BuyALIGN TECHNOLOGY INC$656,746,000
+131.9%
2,353,591
+50.3%
8.18%
+110.1%
TAL SellTAL EDUCATION GROUPsponsored ads$552,623,000
+13.4%
11,465,202
-19.4%
6.88%
+2.8%
ZM NewZOOM VIDEO COMMUNICATIONS INcl a$470,570,0006,916,078
+100.0%
5.86%
UBER BuyUBER TECHNOLOGIES INC$461,018,000
+22.7%
15,501,624
+25.8%
5.74%
+11.3%
BABA SellALIBABA GROUP HLDG LTDsponsored ads$419,898,000
+15.3%
1,979,716
-9.1%
5.23%
+4.5%
JD SellJD COM INCspon adr cl a$419,414,000
-7.8%
11,905,028
-26.1%
5.22%
-16.4%
ESGR  ENSTAR GROUP LIMITED$361,558,000
+8.9%
1,747,8400.0%4.50%
-1.3%
PDD SellPINDUODUO INCsponsored ads$330,145,000
-8.1%
8,729,366
-21.7%
4.11%
-16.7%
CBPO  CHINA BIOLOGIC PRODS HLDGS I$320,185,000
+1.7%
2,751,2000.0%3.99%
-7.9%
BILI SellBILIBILI INCspons ads rep z$190,210,000
+5.0%
10,215,355
-20.4%
2.37%
-4.9%
SE SellSEA LTDsponsored ads$172,946,000
-53.3%
4,300,000
-64.0%
2.16%
-57.6%
FGEN BuyFIBROGEN INC$169,664,000
+31.0%
3,955,787
+12.9%
2.11%
+18.7%
BBIO  BRIDGEBIO PHARMA INC$153,824,000
+63.3%
4,388,6900.0%1.92%
+48.0%
APLS  APELLIS PHARMACEUTICALS INC$143,249,000
+27.1%
4,678,2890.0%1.78%
+15.2%
MDLZ  MONDELEZ INTL INCcl a$140,265,000
-0.4%
2,546,5640.0%1.75%
-9.8%
VIE NewVIELA BIO INC$124,650,0004,591,176
+100.0%
1.55%
BPMC BuyBLUEPRINT MEDICINES CORP$120,533,000
+9.5%
1,504,599
+0.4%
1.50%
-0.8%
GOSS  GOSSAMER BIO INC$92,397,000
-6.9%
5,911,5410.0%1.15%
-15.6%
EDU SellNEW ORIENTAL ED & TECH GRP Ispon adr$73,139,000
-76.1%
603,208
-78.2%
0.91%
-78.3%
SNAP  SNAP INCcl a$72,928,000
+3.4%
4,465,8850.0%0.91%
-6.3%
MYOK  MYOKARDIA INC$71,135,000
+39.8%
975,9870.0%0.89%
+26.6%
NXTC  NEXTCURE INC$59,348,000
+82.6%
1,053,5700.0%0.74%
+65.3%
LN SellLINE CORPsponsored adr$54,958,000
+26.6%
1,121,357
-7.2%
0.68%
+14.7%
MLCO SellMELCO RESORTS AND ENTMT LTDadr$53,122,000
-37.7%
2,197,850
-50.0%
0.66%
-43.6%
NFLX SellNETFLIX INC$44,135,000
-36.8%
136,400
-47.7%
0.55%
-42.7%
BEDU  BRIGHT SCHOLAR ED HLDGS LTDsponsored ads$35,195,000
-8.7%
3,985,7970.0%0.44%
-17.4%
ARVN  ARVINAS INC$35,145,000
+90.7%
855,3080.0%0.44%
+73.1%
GMAB  GENMAB A Ssponsored ads$33,495,000
+10.2%
1,500,0000.0%0.42%
-0.2%
ZLAB  ZAI LAB LTDadr$33,189,000
+28.6%
798,0010.0%0.41%
+16.3%
SDC SellSMILEDIRECTCLUB INC$25,329,000
-37.6%
2,898,086
-0.9%
0.32%
-43.4%
GTHX  G1 THERAPEUTICS INC$25,093,000
+16.0%
949,4310.0%0.31%
+5.4%
MOGU  MOGU INCspon ads$23,818,000
-9.3%
10,446,9700.0%0.30%
-17.7%
KNSA BuyKINIKSA PHARMACEUTICALS LTD$20,969,000
+31.9%
1,895,888
+1.5%
0.26%
+19.7%
AKRO BuyAKERO THERAPEUTICS INC$19,780,000
+16.0%
891,201
+18.9%
0.25%
+5.1%
RGNX  REGENXBIO INC$18,682,000
+15.1%
456,0000.0%0.23%
+4.5%
QCOM NewQUALCOMM INC$17,646,000200,000
+100.0%
0.22%
UXIN SellUXIN LTDads$16,372,000
-29.2%
7,244,341
-23.3%
0.20%
-35.8%
IGMS  IGM BIOSCIENCES INC$13,356,000
+115.0%
350,0000.0%0.17%
+95.3%
HOOK  HOOKIPA PHARMA INC$11,536,000
+63.1%
943,2540.0%0.14%
+48.5%
EIDX  EIDOS THERAPEUTICS INC$10,250,000
+59.6%
178,6000.0%0.13%
+45.5%
SOHU  SOHU COM LTDsponsored ads$8,967,000
+10.0%
802,0340.0%0.11%0.0%
CJJD  CHINA JO-JO DRUGSTORES INC$8,809,000
+50.4%
4,840,0000.0%0.11%
+35.8%
MRUS NewMERUS N V$8,448,000600,000
+100.0%
0.10%
ARGX NewARGENX SEsponsored adr$8,026,00050,000
+100.0%
0.10%
RCUS  ARCUS BIOSCIENCES INC$7,748,000
+11.0%
767,1280.0%0.10%
+1.0%
AMG NewAFFILIATED MANAGERS GROUP IN$6,046,00071,345
+100.0%
0.08%
TXG  10X GENOMICS INC$5,719,000
+51.3%
75,0000.0%0.07%
+36.5%
TCRR  TCR2 THERAPEUTICS INC$4,611,000
-5.0%
322,9030.0%0.06%
-14.9%
CBMG  CELLULAR BIOMEDICINE GROUP I$3,820,000
+9.3%
235,2140.0%0.05%0.0%
CIH  CHINA INDEX HLDGS LTDspnsrd ads a$1,092,000
-6.7%
300,0000.0%0.01%
-12.5%
NEW  PUXIN LTDads$1,034,000
+2.9%
126,1450.0%0.01%
-7.1%
SFUN  FANG HLDGS LTDadr new$858,000
+28.8%
300,0000.0%0.01%
+22.2%
NTGN ExitNEON THERAPEUTICS INC$0-60,000
-100.0%
-0.00%
GSAHWS ExitGS ACQUISITION HLDGS CORP*w exp 06/12/202$0-333,333
-100.0%
-0.01%
CNST ExitCONSTELLATION PHARMCETICLS I$0-246,883
-100.0%
-0.02%
WUBA Exit58 COM INCspon adr rep a$0-57,964
-100.0%
-0.04%
NOAH ExitNOAH HLDGS LTDspon ads cl a$0-481,220
-100.0%
-0.19%
MRNA ExitMODERNA INC$0-978,434
-100.0%
-0.21%
MELI ExitMERCADOLIBRE INC$0-32,600
-100.0%
-0.25%
HTHT ExitHUAZHU GROUP LTDsponsored ads$0-611,490
-100.0%
-0.28%
NIO ExitNIO INCspon ads$0-13,368,900
-100.0%
-0.29%
SQ ExitSQUARE INCcl a$0-428,675
-100.0%
-0.36%
AAPL ExitAPPLE INC$0-127,759
-100.0%
-0.39%
TSLA ExitTESLA INC$0-171,400
-100.0%
-0.57%
MOMO ExitMOMO INCadr$0-1,385,000
-100.0%
-0.59%
CVET ExitCOVETRUS INC$0-3,958,198
-100.0%
-0.65%
AMZN ExitAMAZON COM INC$0-48,456
-100.0%
-1.16%
FB ExitFACEBOOK INCcl a$0-1,280,763
-100.0%
-3.14%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BEIGENE LTD20Q3 202326.0%
JD.COM INC20Q3 202313.1%
IQIYI INC20Q3 202312.3%
MONDELEZ INTL INC20Q3 20235.9%
KINIKSA PHARMACEUTICALS LTD20Q3 20231.6%
SOHU COM LTD20Q3 20230.6%
PINDUODUO INC19Q3 202316.1%
GOSSAMER BIO INC19Q3 20232.3%
BRIDGEBIO PHARMA INC18Q3 20233.4%
MELCO RESORTS AND ENTMT LTD18Q1 20232.8%

View HHLR ADVISORS, LTD.'s complete holdings history.

Latest significant ownerships (13-D/G)
HHLR ADVISORS, LTD. Q4 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
I-MabJune 30, 202315,891,2118.3%
BeiGene, Ltd.February 14, 2023147,043,05810.9%
Gossamer Bio, Inc.February 14, 20234,974,0415.3%
On Holding AGFebruary 14, 20235,468,5041.9%
Root, Inc.February 14, 2023138,9771.5%
Yatsen Holding LtdFebruary 14, 2023300,560,60219.1%
iQIYI, Inc.July 11, 2022149,075,9125.0%
Apellis Pharmaceuticals, Inc.February 14, 2022? ?
Beam Therapeutics Inc.February 14, 2022? ?
Futu Holdings LtdFebruary 14, 20222-

View HHLR ADVISORS, LTD.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
42024-02-01
13F-HR2023-11-14

View HHLR ADVISORS, LTD.'s complete filings history.

Compare quarters

Export HHLR ADVISORS, LTD.'s holdings